| Dr Pariya Tabarsi, DMD | |
|
1310 Third Ave Ste C304, Chula Vista, CA 91911-4371 | |
| (888) 630-5550 | |
| Not Available |
| Full Name | Dr Pariya Tabarsi |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 1310 Third Ave Ste C304, Chula Vista, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962276386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 108868 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pariya Tabarsi, DMD 1310 Third Ave Ste C304, Chula Vista, CA 91911-4371 Ph: (888) 630-5550 | Dr Pariya Tabarsi, DMD 1310 Third Ave Ste C304, Chula Vista, CA 91911-4371 Ph: (888) 630-5550 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced that the European Commission has approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. FIRAZYR is the first and only treatment for acute Type I and Type II hereditary angioedema (HAE) attacks licensed for self-administration in Europe.
Tread lightly and don't get too confident; winter is officially here and sidewalks are slippery. About 1 million people take a tumble every year and, according to the Centers for Disease Control and Prevention, approximately 20,000 people die annually due to fall-related injuries.
Drinking two cups of hot chocolate a day may help older people keep their brains healthy and their thinking skills sharp, according to a study published in the August 7, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with recurrent liver cancer. PV-10 is the company's lead oncology drug candidate that is also currently undergoing Phase 2 study for metastatic melanoma.
Boston Scientific Corporation (NYSE: BSX) today announced that Ken Stein, M.D., FACC, will join the Company as Senior Vice President and Associate Chief Medical Officer for its Cardiac Rhythm Management (CRM) group. Dr. Stein is currently the Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University.
› Verified 3 days ago
Dr. Federico G Drachenberg, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 890 Eastlake Parkway, Ste 101, Chula Vista, CA 91914 Phone: 619-934-3258 Fax: 619-651-7578 | |
Evelyn Lugue Salazar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1101 Broadway, Chula Vista, CA 91911 Phone: 619-422-8891 Fax: 619-422-4356 | |
Dr. Graciela L Lopez, DDS Dentist Medicare: Medicare Enrolled Practice Location: 301 3rd Ave, Chula Vista, CA 91910 Phone: 619-476-1444 Fax: 619-476-0656 | |
Luis E Real, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 690 E St, Chula Vista, CA 91910 Phone: 619-425-2122 Fax: 619-425-2125 | |
Karen Yong Liu, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 885 Canarios Court, Suite 202, Chula Vista, CA 91910 Phone: 619-656-6800 Fax: 619-656-0200 | |
Dr. Mercedes F Razo, D.D.S,M.A.G.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 885 Canarios Ct, #210, Chula Vista, CA 91910 Phone: 619-656-4199 Fax: 619-656-6945 | |
Ruth Garcia Rosas, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2452 Fenton St Ste 200, Chula Vista, CA 91914 Phone: 619-934-6620 |